Term pregnancy with intraperitoneal levonorgestrel intrauterine system: a case report and review of the literature

Contraception

Volumn 79, Issue 4, 2009, Pages 323-327

  Hopkins, Matthew R ^a   Agudelo Suarez, Patricia ^a   El Nashar, Sherif A ^a   Creedon, Douglas J ^a   Rose, Carl H ^a   Famuyide, Abimbola O ^a  

^a MAYO CLINIC   (United States)

Author keywords

Contraception; IUD; Levonorgestrel; Perforation; Pregnancy

Indexed keywords

LEVONORGESTREL;

ABDOMINAL PAIN; ADULT; ARTICLE; CASE REPORT; CESAREAN SECTION; CONGENITAL MALFORMATION; CONTRACEPTION; DEVICE; DEVICE DISPLACEMENT; DEVICE REMOVAL; ELECTIVE SURGERY; FEMALE; HUMAN; INTRAUTERINE CONTRACEPTIVE DEVICE; OUTCOME ASSESSMENT; PELVIS PAIN SYNDROME; PELVIS RADIOGRAPHY; PERITONEAL BIOPSY; PERITONEAL CAVITY; PREGNANCY; PREGNANT WOMAN; PRENATAL DRUG EXPOSURE; TRANSVAGINAL ECHOGRAPHY; UTERUS PERFORATION;

ADULT; CESAREAN SECTION; FEMALE; FOREIGN-BODY MIGRATION; HUMANS; INFANT, NEWBORN; INTRAUTERINE DEVICES, MEDICATED; LEVONORGESTREL; MALE; PREGNANCY; PREGNANCY OUTCOME;

EID: 61549111574     PISSN: 00107824     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.contraception.2008.10.008     Document Type: Article

References (40)

1. United Nations Department of Economic and Social Affairs, Population Division. World contraceptive use 2005 [datasets in Excel format] (2006), United Nations, New York
2. d'Arcangues C. Worldwide use of intrauterine devices for contraception. Contraception 75 6 Suppl (2007) S2-S7 [Epub 2007 Apr 19]
3. Gallup organization. A survey of female ob-gyns on health issues and concerns conducted for the American College of Obstetricians and Gynecologists, December 2003. ACOG Today 2004;48:1,6-7.
4. Backman T., Rauramo I., Huhtala S., and Koskenvuo M. Pregnancy during the use of levonorgestrel intrauterine system. Am J Obstet Gynecol 190 (2004) 50-54
5. World Health Organization. Mechanism of action, safety and efficacy of intrauterine devices: report of a WHO scientific group. World Health Organ Tech Rep Ser 753 (1987) 1-91
6. Jensen J.T., Nelson A.L., and Costales A.C. Subject and clinician experience with the levonorgestrel-releasing intrauterine system. Contraception 77 (2008) 22-29 [Epub 2007 Nov 26]
7. Prager S., and Darney P.D. The levonorgestrel intrauterine system in nulliparous women. Contraception 75 6 Suppl (2007) S12-S15 [Epub 2007 Apr 3]
8. Andersson K., Ryde-Blomqvist E., Lindell K., Odlind V., and Milsom I. Perforations with intrauterine devices: report from a Swedish survey. Contraception 57 (1998) 251-255
9. Mirena (levonorgestrel-releasing intrauterine system) [prescribing information] (2007), Bayer HealthCare Pharmaceuticals Inc, Wayne (NJ)
10. Landis J.R., and Koch G.G. The measurement of observer agreement for categorical data. Biometrics 33 (1977) 159-174
11. Budiman H., Kumper C., Mylonas I., Thaler C.J., Friese K., and Weissenbacher E.R. Pregnancy in a patient with a displaced levonorgestrel-releasing intrauterine system: a case report. Arch Gynecol Obstet 276 (2007) 263-264 [Epub 2007 Mar 14]
12. Trussell J. Contraceptive efficacy. In: Hatcher R.A., Trussell J., Steward F., et al. (Eds). Contraceptive technology. 18th ed. (2004), Ardent Media Inc, New York 773-845
13. Nitke S., Rabinerson D., Dekel A., Sheiner E., Kaplan B., and Hackmon R. Lost levonorgestrel IUD: diagnosis and therapy. Contraception 69 (2004) 289-293
14. Van Houdenhoven K., van Kaam K.J., van Grootheest A.C., Salemans T.H., and Dunselman G.A. Uterine perforation in women using a levonorgestrel-releasing intrauterine system. Contraception 73 (2006) 257-260 [Epub 2005 Oct 21]
15. Ingec M., Kumtepe Y., Kadanali S., and Ozdiller O. A rare case of ileal embedding by an intrauterine device. Eur J Contracept Reprod Health Care 10 (2005) 29-31
16. Kiilholma P., Makinen J., and Vuori J. Bladder perforation: uncommon complication with a misplaced IUD. Adv Contracept 5 (1989) 47-49
17. Tuncay Y.A., Tuncay E., Guzin K., Ozturk D., Omurcan C., and Yucel N. Transuterine migration as a complication of intrauterine contraceptive devices: six case reports. Eur J Contracept Reprod Health Care 9 (2004) 194-200
18. International Planned Parenthood Federation (IPPF): International Medical Advisory Panel (IMAP). Statement on intrauterine devices (IUDs). IPPF Med Bull 21 (1987) 3-5
19. Duramed Pharmaceutical. ParaGard (T 380A intrauterine copper contraceptive) [prescribing information] (2006), Duramed Pharmaceuticals Inc, Pomona (NY)
20. Markovitch O., Klein Z., Gidoni Y., Holzinger M., and Beyth Y. Extrauterine mislocated IUD: is surgical removal mandatory?. Contraception 66 (2002) 105-108
21. Ozgun M.T., Batukan C., Serin I.S., Ozcelik B., Basbug M., and Dolanbay M. Surgical management of intra-abdominal mislocated intrauterine devices. Contraception 75 (2007) 96-100 [Epub 2006 Dec 8]
22. Haimov-Kochman R., Doviner V., Amsalem H., Prus D., Adoni A., and Lavy Y. Intraperitoneal levonorgestrel-releasing intrauterine device following uterine perforation: the role of progestins in adhesion formation. Hum Reprod 18 (2003) 990-993
23. Lethaby A.E., Cooke I., and Rees M. Progesterone or progestogen-releasing intrauterine systems for heavy menstrual bleeding. Cochrane Database Syst Rev 4 (2005) CD002126 10.1002/14651858.CD002126.pub2
24. Schardein J.L. Congenital abnormalities and hormones during pregnancy: a clinical review. Teratology 22 (1980) 251-270
25. Raman-Wilms L., Tseng A.L., Wighardt S., Einarson T.R., and Koren G. Fetal genital effects of first-trimester sex hormone exposure: a meta-analysis. Obstet Gynecol 85 (1995) 141-149
26. Kallen B., Mastroiacovo P., Lancaster P.A., et al. Oral contraceptives in the etiology of isolated hypospadias. Contraception 44 (1991) 173-182
27. Carmichael S.L., Shaw G.M., Laurent C., Croughan M.S., Olney R.S., and Lammer E.J. Maternal progestin intake and risk of hypospadias. Arch Pediatr Adolesc Med 159 (2005) 957-962
28. Jacobson B.D. Hazards of norethindrone therapy during pregnancy. Am J Obstet Gynecol 84 (1962) 962-968
29. Nora J.J., and Nora A.H. Contraceptive hormones and congenital heart disease. Teratology 15 (1977) 331-332
30. Janerich D.T., Dugan J.M., Standfast S.J., and Strite L. Congenital heart disease and prenatal exposure to exogenous sex hormones. Br Med J 1 (1977) 1058-1060
31. Heinonen O.P., Slone D., Monson R.R., Hook E.B., and Shapiro S. Cardiovascular birth defects and antenatal exposure to female sex hormones. N Engl J Med 296 (1977) 67-70
32. Resseguie L.J., Hick J.F., Bruen J.A., Noller K.L., O'Fallon W.M., and Kurland L.T. Congenital malformations among offspring exposed in utero to progestins, Olmsted County, Minnesota, 1936-1974. Fertil Steril 43 (1985) 514-519
33. Katz Z., Lancet M., Skornik J., Chemke J., Mogilner B.M., and Klinberg M. Teratogenicity of progestogens given during the first trimester of pregnancy. Obstet Gynecol 65 (1985) 775-780
34. De Santis M., Cavaliere A.F., Straface G., Carducci B., and Caruso A. Failure of the emergency contraceptive levonorgestrel and the risk of adverse effects in pregnancy and on fetal development: an observational cohort study. Fertil Steril 84 (2005) 296-299
35. Houston A. Pregnancy while using Norplant. Br J Fam Plann 24 (1998) 29-30
36. Jordan A. Toxicology of progestogens of implantable contraceptives for women. Contraception 65 (2002) 3-8
37. Haimov-Kochman R., Amsalem H., Adoni A., Lavy Y., and Spitz I.M. Management of a perforated levonorgestrel-medicated intrauterine device: a pharmacokinetic study: case report. Hum Reprod 18 (2003) 1231-1233
38. Wilson J.G., and Brent R.L. Are female sex hormones teratogenic?. Am J Obstet Gynecol 141 (1981) 567-580
39. Simpson J.L., and Holzgreve W. Genetic counseling and genetic screening. In: Gabbe S.G., Niebyl J.R., and Simpson J.L. (Eds). Obstetrics: normal and problem pregnancies. 5th ed. (2007), Churchill Livingstone, Philadelphia 139-151
40. Al-Fozan H., and Tulandi T. Safety and risks of laparoscopy in pregnancy. Curr Opin Obstet Gynecol 14 (2002) 375-379